14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0701 $0.0701 Monday, 3rd Apr 2023 PHAS stock ended at $0.0701. During the day the stock fluctuated 0% from a day low at $0.0701 to a day high of $0.0701.
90 days $0.0300 $0.0701
52 weeks $0.0100 $1.69

Historical PhaseBio Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Dec 15, 2021 $2.24 $2.33 $2.11 $2.29 294 602
Dec 14, 2021 $2.20 $2.32 $2.20 $2.27 227 601
Dec 13, 2021 $2.33 $2.36 $2.22 $2.27 356 532
Dec 10, 2021 $2.32 $2.37 $2.22 $2.36 521 466
Dec 09, 2021 $2.23 $2.37 $2.20 $2.30 641 572
Dec 08, 2021 $2.10 $2.31 $2.03 $2.26 674 814
Dec 07, 2021 $2.10 $2.12 $2.01 $2.08 652 152
Dec 06, 2021 $1.96 $2.03 $1.83 $2.00 487 734
Dec 03, 2021 $1.99 $2.01 $1.88 $1.95 833 883
Dec 02, 2021 $1.93 $2.00 $1.85 $1.99 776 565
Dec 01, 2021 $2.13 $2.13 $1.87 $1.90 1 300 568
Nov 30, 2021 $2.14 $2.14 $2.03 $2.08 910 919
Nov 29, 2021 $2.34 $2.36 $2.12 $2.16 808 778
Nov 26, 2021 $2.28 $2.37 $2.20 $2.27 468 932
Nov 24, 2021 $2.25 $2.41 $2.15 $2.37 666 650
Nov 23, 2021 $2.31 $2.35 $2.09 $2.22 909 704
Nov 22, 2021 $2.37 $2.39 $2.27 $2.29 670 442
Nov 19, 2021 $2.58 $2.59 $2.15 $2.36 1 619 259
Nov 18, 2021 $2.83 $2.83 $2.53 $2.54 1 384 897
Nov 17, 2021 $2.90 $2.96 $2.70 $2.78 1 573 709
Nov 16, 2021 $3.10 $3.20 $2.92 $2.95 1 407 335
Nov 15, 2021 $3.75 $4.08 $2.93 $3.02 4 145 976
Nov 12, 2021 $3.87 $3.96 $3.65 $3.70 996 363
Nov 11, 2021 $3.45 $3.89 $3.45 $3.84 985 394
Nov 10, 2021 $3.54 $3.58 $3.39 $3.45 747 755

FAQ

What are historical stock prices?
Historical stock prices refer to a stock’s recorded prices at various past points. These prices include several key figures that help investors and analysts evaluate a stock’s performance over time:
Open: Open price for the trading day.
High: Highest price for the trading day.
Low: Lowest price for the trading day.
Close: Close price for the trading day.

Additionally, historical prices often include:
Volume is the number of shares traded during the day. It indicates how actively a stock was traded and can provide insights into market sentiment and liquidity.

How can I use PHAS stock historical prices to predict future price movements?
Trend Analysis: Examine the PHAS stock’s historical trends to identify patterns that might continue.
Moving Averages: Use moving averages to detect potential reversal points.
Momentum Indicators: Apply indicators like RSI or MACD to assess the momentum and strength of price movements.
Volume Analysis: Analyze trading volume alongside price changes to gauge trend strength.
Statistical Methods: Use statistical tools such as regression analysis to model and forecast future prices based on past data.
These techniques can provide insights but should be used with risk management practices to mitigate potential losses.

What impact do stock splits have on historical price data?
When a company performs a stock split, it adjusts the historical price data to reflect the new, lower trading price as if it had always been that way.

This ensures consistency for anyone analyzing the stock’s past prices. The adjustment helps prevent misleading signals on charts, such as false sell signals or bearish trends that aren’t there. For instance, in a 2-for-1 stock split, the price per share is cut in half, which would otherwise appear as a dramatic drop on the chart. If someone didn’t know about the split, they might wrongly think something negative happened to the company. Most technical indicators would also react to this apparent drop by signaling to sell.

A stock split, while making the shares seem more affordable and potentially more attractive to investors, doesn’t alter the company’s fundamental value.

Why do the PHAS stock historical prices show a range for periods like 30 days, 90 days, and 52 weeks?
The range provides the lowest and highest prices at which the stock has traded during the specified period. This helps investors understand the stock’s volatility and price variability within that timeframe.

How can I use historical price volatility to assess risk?
High price volatility historically indicates higher risk and potentially higher returns. Investors can gauge the stock’s risk level by examining the range between high and low prices over various periods.
Click to get the best stock tips daily for free!

About PhaseBio Pharmaceuticals Inc.

PhaseBio Pharmaceuticals. PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiovascular diseases. Its lead product candidate is bentracimab (PB2452), a reversal agent for the antiplatelet drug ticagrelor that is in Phase III clinical trial for patients with uncontrolled major or life-threatening bleeding events or in patients requiring urgent or an invasive procedure. The company is... PHAS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT